Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (201-210 of 477) with videos related to

Pageof 48
Sort By:
Clinical Rheumatology|February 13, 2019
Utilize lung ultrasound B-lines and KL-6 to monitor anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a case report and literature reviewYukai Wang, Shaoqi Chen, Zhangzhang Lin, et al.
Rheumatology (Oxford, England)|July 17, 2009
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trialsMarian Kaldas, Puja P Khanna, Daniel E Furst, et al.
Arthritis Care & Research|October 10, 2012
Publication outcomes of abstracts presented at an American College of Rheumatology/Association of Rheumatology Health Professionals annual scientific meetingGil Amarilyo, Jennifer M P Woo, Daniel E Furst, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
British Journal of Clinical Pharmacology|April 6, 2021
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjectsAntonia Davidson, Darin Brimhall, Jonathan Kay, et al.
The Journal of Rheumatology|July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentDinesh Khanna, Daniel E Furst, Paul Maranian, et al.
The Journal of Rheumatology|August 3, 2011
OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in healthJohn R Kirwan, Annelies Boonen, Mark J Harrison, et al.
The Journal of Rheumatology|April 17, 2009
Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritisSogol S Amjadi, Paul M Maranian, Harold E Paulus, et al.
Arthritis Care & Research|June 26, 2012
Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patientsDamini Jawaheer, Susan Messing, George Reed, et al.
Rheumatology (Oxford, England)|February 9, 2021
Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population-a multicentre studyYoel Levinsky, Mor Broide, Shelly Kagan, et al.
Pageof 48

Showing results (201-210 of 477) with videos related to

Sort By:
Pageof 48
Clinical Rheumatology|February 13, 2019
Utilize lung ultrasound B-lines and KL-6 to monitor anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis-associated interstitial lung disease: a case report and literature reviewYukai Wang, Shaoqi Chen, Zhangzhang Lin, et al.
Rheumatology (Oxford, England)|July 17, 2009
Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trialsMarian Kaldas, Puja P Khanna, Daniel E Furst, et al.
Arthritis Care & Research|October 10, 2012
Publication outcomes of abstracts presented at an American College of Rheumatology/Association of Rheumatology Health Professionals annual scientific meetingGil Amarilyo, Jennifer M P Woo, Daniel E Furst, et al.
Rheumatology (Oxford, England)|October 2, 2010
Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosisVijay Bodukam, Ron D Hays, Paul Maranian, et al.
British Journal of Clinical Pharmacology|April 6, 2021
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjectsAntonia Davidson, Darin Brimhall, Jonathan Kay, et al.
The Journal of Rheumatology|July 5, 2011
Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract InstrumentDinesh Khanna, Daniel E Furst, Paul Maranian, et al.
The Journal of Rheumatology|August 3, 2011
OMERACT 10 Patient Perspective Virtual Campus: valuing health; measuring outcomes in rheumatoid arthritis fatigue, RA sleep, arthroplasty, and systemic sclerosis; and clinical significance of changes in healthJohn R Kirwan, Annelies Boonen, Mark J Harrison, et al.
The Journal of Rheumatology|April 17, 2009
Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritisSogol S Amjadi, Paul M Maranian, Harold E Paulus, et al.
Arthritis Care & Research|June 26, 2012
Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patientsDamini Jawaheer, Susan Messing, George Reed, et al.
Rheumatology (Oxford, England)|February 9, 2021
Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population-a multicentre studyYoel Levinsky, Mor Broide, Shelly Kagan, et al.
Pageof 48